Status:
UNKNOWN
Virtual Reality (VR) Diagnostic Tool for Attention Deficits/Hyperactivity Disorder (ADHD)
Lead Sponsor:
Tjhin Wiguna
Collaborating Sponsors:
Fakultas Kedokteran Universitas Indonesia
Dr Cipto Mangunkusumo General Hospital
Conditions:
ADHD
Executive Dysfunction
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
Attention deficit/ hyperactivity disorder (ADHD) is a common neurodevelopmental disorder. The common diagnostic of ADHD is based on psychiatric examination and interview. So far, there is not any othe...
Detailed Description
Diagnostic test is a very essential in modern medical practices, especially in child and adolescent psychiatry field because the main diagnostic tool is only based on psychiatry interview and observat...
Eligibility Criteria
Inclusion
- Inclusion Criteria for ADHD group:
- Children with ADHD drug naive
- Parent willing to participate in the study by signing informed consent
- Children willing to participate the ADHD-VR diagnostic tool for at least 30 minutes
- Exclusion Criteria:
- Having untreated chronic physical illnesses
- Having other mental disorders except ADHD
- Inclusion Criteria for healthy children group:
- Do not have any mental disorder
- Do not have untreated chronic physical illnesses
- Parent willing to participate in the study by signing informed consent
- Children willing to participate the ADHD-VR diagnostic tool for at least 30 minutes
Exclusion
Key Trial Info
Start Date :
May 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04337905
Start Date
May 25 2019
End Date
July 31 2021
Last Update
April 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
dr. Cipto Mangunkusumo General Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430